1. Home
  2. ASMB vs DIT Comparison

ASMB vs DIT Comparison

Compare ASMB & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • DIT
  • Stock Information
  • Founded
  • ASMB 2005
  • DIT 1981
  • Country
  • ASMB United States
  • DIT United States
  • Employees
  • ASMB N/A
  • DIT N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • DIT Food Distributors
  • Sector
  • ASMB Health Care
  • DIT Consumer Discretionary
  • Exchange
  • ASMB Nasdaq
  • DIT Nasdaq
  • Market Cap
  • ASMB 76.9M
  • DIT 78.7M
  • IPO Year
  • ASMB 2010
  • DIT 1995
  • Fundamental
  • Price
  • ASMB $15.40
  • DIT $108.02
  • Analyst Decision
  • ASMB Strong Buy
  • DIT
  • Analyst Count
  • ASMB 3
  • DIT 0
  • Target Price
  • ASMB $33.00
  • DIT N/A
  • AVG Volume (30 Days)
  • ASMB 14.3K
  • DIT 119.0
  • Earning Date
  • ASMB 05-08-2025
  • DIT 07-17-2025
  • Dividend Yield
  • ASMB N/A
  • DIT 0.67%
  • EPS Growth
  • ASMB N/A
  • DIT N/A
  • EPS
  • ASMB N/A
  • DIT 2.44
  • Revenue
  • ASMB $32,154,000.00
  • DIT $2,221,421,072.00
  • Revenue This Year
  • ASMB $33.96
  • DIT N/A
  • Revenue Next Year
  • ASMB N/A
  • DIT N/A
  • P/E Ratio
  • ASMB N/A
  • DIT $46.29
  • Revenue Growth
  • ASMB 148.33
  • DIT 7.47
  • 52 Week Low
  • ASMB $7.75
  • DIT $99.87
  • 52 Week High
  • ASMB $19.93
  • DIT $166.00
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 69.79
  • DIT 38.61
  • Support Level
  • ASMB $13.13
  • DIT $111.56
  • Resistance Level
  • ASMB $14.35
  • DIT $113.42
  • Average True Range (ATR)
  • ASMB 0.73
  • DIT 1.61
  • MACD
  • ASMB 0.10
  • DIT -0.24
  • Stochastic Oscillator
  • ASMB 84.79
  • DIT 0.00

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: